➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Mallinckrodt
Baxter
Colorcon
Boehringer Ingelheim

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

Litigation Details for Bayer Schering Pharma AG v. Lupin Ltd (D. Nev. 2010)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Bayer Schering Pharma AG v. Lupin Ltd (D. Nev. 2010)

Docket   Start Trial Date Filed 2010-07-15
Court District Court, D. Nevada Date Terminated 2013-11-27
Cause 35:271 Patent Infringement Assigned To Kent J. Dawson
Jury Demand Plaintiff Referred To Robert J. Johnston
Parties BAYER HEALTHCARE PHARMACEUTICALS INC.; BAYER SCHERING PHARMA AG; LUPIN LTD; LUPIN PHARMACEUTICALS INC.
Patents 6,787,531; 6,933,395; 6,958,326; 6,987,101; 7,163,931
Attorneys Adam K Mortara; Christopher T Griffith; James E Whitmire, III; Jonathan W Fountain; Kate M Lesciotto; Matthew R. Ford; Michael J. McCue; Nikkya G. Williams; Paul J Skiermont; Peter B. Bensinger , Jr.; Robert F. Green; Salim A Hasan; Sundeep K. Addy
Link to Docket External link to docket
Small Molecule Drugs cited in Bayer Schering Pharma AG v. Lupin Ltd
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Bayer Schering Pharma AG v. Lupin Ltd (D. Nev. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-09-27 10 listed U.S. Patent Nos. 5,569,652 (“the ’652 patent”), 5,798,338 (“the ’338 patent”), 6,787,531 (“the ’531…Certification with respect to U.S. Patent Nos. 5,569,652; 5,798,338; 6,787,531; 6,933,395; 6,958,326; 7,163,…531 patent”), 6,933,395 (“the ’395 patent”), 6,958,326 (“the ’326 patent”), 6,987,101 (“the ’101 patent…the ’931 patent”), RE 37,564 (“the ’564 reissue patent”), RE 37,838 (“the ’838 reissue patent”), RE 38,253…holder/patent holder; (2) neither the NDA holder nor the patent holder has filed a suit for patent infringement External link to document
2011-07-22 85 Regarding U.S. Reissue Patent Nos. 37,838 and 38,253 and U.S. Patent Nos. 5,798,338, 6,933,395, 6,958,326, and… 27 November 2013 2:10-cv-01166 830 Patent Plaintiff District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Colorcon
Boehringer Ingelheim
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.